Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

Share Price is delayed by 15 minutes
Get Live Data
11.275    0.00 (0.00%)
Bid:
10.80
Ask:
11.75
Spread: 0.95 (8.796%)
Market Cap: £31.38m
VSL Live PriceLast checked at - London Stock Exchange

Intraday Vpc Specialty Share Chart

Net Asset Value(s)

12 Jan 2026 16:01

RNS Number : 5748O
VPC Specialty Lending Invest. PLC
12 January 2026
 

12 January 2026

VPC Specialty Lending Investments PLC

(the "Company")

QUARTERLY NET ASSET VALUE

In the Quarterly Report for the Third Quarter of 2025, the Company referred to the merger of Whele, LLC ("Razor Group" or "Razor") and Infinite Commerce on 28 August 2025. Following the completion of that merger, business performance of the newly combined entity has been poorer than anticipated and it is expected that the year-end valuation of Razor will be substantially lower than disclosed as at 30 September 2025 (https://vpcspecialtylending.com/). This is expected to have a material adverse impact on the Company's NAV overall, which will be reflected in the NAV as at 31 December 2025. More details will be included in the Quarterly Report for the Fourth Quarter of 2025.

The information contained in this announcement is inside information and is price sensitive. The entity responsible for arranging for the release of this announcement on behalf of VSL is MUFG Corporate Governance Limited.

 

Enquiries

For further information, please contact:

VPC Specialty Lending Investments PLC Nick Campsie

Victory Park Capital

Gordon Watson

via Victory Park Capital (below)

info@vpcspecialtylending.com

About VPC Specialty Lending Investments PLC

VPC Specialty Lending Investments PLC (Company No. 9385218) is a UK listed investment trust focused on asset-backed lending to emerging and established businesses with the goal of building long-term, sustainable income generation. The Company identifies investment opportunities across various industries and geographies to offer shareholders access to a diversified portfolio of opportunistic credit investments originated by non-bank lenders with a focus on the rapidly developing technology-enabled lending sector.

 

This document is for information purposes only and is not an offer to invest. All investments are subject to risk. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results.

 

LEI: 549300UPEXC5DQB81P34

 

 

 

 

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVUUVVRNKUAAAR
Date   Source Headline
13th Nov 20247:00 amRNSDividend Declaration
29th Oct 202410:40 amRNSReappointment of PwC
8th Oct 20249:41 amRNSNet Asset Value(s)
24th Sep 20242:32 pmRNSChange to Directors' Responsibilities
20th Sep 20247:00 amRNSHalf-year Report
10th Sep 20247:00 amRNSNet Asset Value(s)
29th Aug 20247:00 amRNSDividend Declaration
13th Aug 20247:00 amRNSUpdate Regarding Investment Manager
8th Aug 20247:00 amRNSNet Asset Value(s)
10th Jul 20247:00 amRNSNet Asset Value(s)
13th Jun 20247:00 amRNSDividend Declaration
12th Jun 20246:21 pmRNSResult of AGM
12th Jun 20247:05 amRNSQuarterly Presentation
12th Jun 20247:00 amRNSNet Asset Value(s)
6th Jun 20245:26 pmRNSAppointment of Directors
20th May 20247:00 amRNSNet Asset Value(s)
2nd May 20244:27 pmRNSNotice of AGM
24th Apr 20247:00 amRNSAnnual Financial Report
22nd Apr 20247:00 amRNSNet Asset Value(s)
17th Apr 20244:30 pmRNSInitial Return of Capital Exchange Ratio
9th Apr 20247:00 amRNSInitial Return of Capital through B Share Scheme
5th Apr 202411:23 amRNSResult of General Meeting
15th Mar 20247:00 amRNSPublication of circular relating to B share scheme
8th Mar 20243:00 pmRNSNet Asset Value(s)
22nd Feb 20248:54 amRNSReplacement - Dividend Declaration
22nd Feb 20247:00 amRNSDividend Declaration
7th Feb 20249:00 amRNSNet Asset Value(s)
17th Jan 20247:00 amRNSNet Asset Value(s)
8th Dec 20237:00 amRNSNet Asset Value(s)
17th Nov 20237:00 amRNSDividend Declaration
13th Nov 20237:00 amRNSNet Asset Value and Monthly Report
5th Oct 20237:00 amRNSNet Asset Value and Monthly Report
29th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSNet Asset Value and Monthly Report
24th Aug 20237:00 amRNSDividend Declaration
8th Aug 20231:21 pmRNSNet Asset Value and Monthly Report
13th Jul 202311:45 amRNSNet Asset Value(s) and Monthly Report
26th Jun 20237:00 amRNSDividend Declaration
23rd Jun 20235:08 pmRNSResult of AGM
12th Jun 20235:31 pmRNSResult of Meeting
7th Jun 20237:00 amRNSNet Asset Value(s)
31st May 20231:26 pmRNSDirectorate Change and Notice of AGM
16th May 20232:58 pmRNSCircular containing a Notice of General Meeting
11th May 202310:07 amRNSNet Asset Value(s)
28th Apr 20237:00 amRNSAnnual Financial Report
11th Apr 20235:33 pmRNSHolding(s) in Company
6th Apr 20237:00 amRNSNet Asset Value(s)
7th Mar 20237:00 amRNSNet Asset Value(s)
22nd Feb 20237:00 amRNSDividend Declaration
10th Feb 20237:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.